Trials / Completed
CompletedNCT00163735
Potential Allergens in Wine: Double-blind Placebo-controlled Trial
Potential Allergens in Wine: Double Blind Placebo-controlled Trial and Basophil Activation Analysis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Bayside Health · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to identify whether wines which are produced using the common potential food allergens such as proteins derived from fish, milk or egg are likely to contain sufficient food allergens to cause allergic reactions in susceptible individuals.
Detailed description
Recent international legislation requires labelling of wines made using potentially allergenic food proteins "casein", egg white, isinglass ( fish derived), milk or evaporated milk where "there is detectable residual processing aid". However it is not clear whether the final wine contains concentrations of residual added food proteins that can provoke allergic reactions. Comparison:This study is a double blind, placebo-controlled trial to determine whether adults known to be allergic to eggs, fish, milk and/or nuts exhibit allergic reactions following consumption of Australian commercial wines fined with food allergens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Administration of wine fined with potential food allergens |
Timeline
- Start date
- 2002-08-01
- Primary completion
- 2006-05-01
- Completion
- 2006-05-01
- First posted
- 2005-09-14
- Last updated
- 2013-12-05
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT00163735. Inclusion in this directory is not an endorsement.